New ZealandMarket Access for Product-Registration in New Zealand
Navigating the complexities of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve timely and profitable entry into diverse international ma
6 Pillars of Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
Global Regulatory Intelligence
Understanding the intricate and evolving regulatory landscapes across key markets is fundamental. We provide deep insights into country-specific requirements for product registration.
How It Works
A structured engagement — typically delivered in a few weeks.
Discovery & Landscape Analysis
We begin with a deep dive into your product's profile, target indications, and existing clinical data, coupled with a comprehensive analysis of target global markets and regulatory pathways.
Market Overview: Global + Product-Registration
Increasing Regulatory Divergence
Global product registration faces growing challenges due to divergent regulatory requirements and escalating data demands across different jurisdictions, necessitating nuanced market access strategies.
Payer Scrutiny and Value-Based Access
Payers globally are intensifying their scrutiny of product value, demanding robust real-world evidence and outcomes-based agreements, shifting focus from efficacy to demonstrable value for money.
Digitalization of Health & Data Integration
The rise of digital health solutions and integrated data platforms presents both opportunities and complexities for market access, requiring new approaches to evidence generation and stakeholder communication.
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy
A detailed roadmap outlining optimal pathways for product registration, pricing, and reimbursement in target markets.
Health Technology Assessment (HTA) Dossier Guidance
Strategic advice and support for developing compelling HTA submissions that demonstrate clinical and economic value.
Global Pricing & Reimbursement Model
An analytical framework and recommendations for establishing competitive and sustainable pricing across diverse international markets.
Stakeholder Engagement & Advocacy Plan
A targeted strategy for engaging key opinion leaders, patient organizations, and policy makers to build support for your product.
Use Cases
First Global Launch of a Novel Therapy
A biotech firm with a breakthrough oncology therapy needs to navigate simultaneous registration and market access in the EU, US, and Japan, lacking internal global expertise.
Related Services
Frequently Asked Questions
Ready to Start Market Access in Global?
Unlock the full potential of your life sciences product with a strategic partner dedicated to global success. Our expertise ensures efficient navigation of complex regulatory and market landscapes.